Onconova Therapeutics Inc... (ONTX)
NASDAQ: ONTX
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Apr 02, 2024, 10:00 PM
Onconova Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 228.79B | 226.11B | 226.06B | 57.17M | 57.17M | 226K | 226K | 226K | 226K | 226K | 226K | 226K | 226K | 226K | 226K | 227K | 236K | 235K |
Cost of Revenue | 117,464B | 117,464B | 117,464B | 12K | 17K | 21K | 24K | 16K | 14K | 14K | 11K | 7K | 4K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -117,238B | -117,238B | -117,238B | 100K | 152K | 205K | 202K | 210K | 212K | 212K | 215K | 219K | 222K | 226K | 226K | 227K | 236K | 235K |
Operating Income | -142,257.1B | -142,379.2B | -142,374B | -19.23M | -123.36B | -19.37M | -20.3M | -21.57M | -22.12M | -21.63M | -19.63M | -17.66M | -16M | -16.53M | -16.5M | -18.99M | -21.27M | -23.97M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 651K | 651K | 651K | 651K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -166,379.3B | -166,501.5B | -166,523B | -18.09M | -123.16B | -18.16M | -18.95M | -20.18M | -20.84M | -20.62M | -18.96M | -17.31M | -15.36M | -15.57M | -16.16M | -18.82M | -21.61M | -24.78M |
Net Income | -166,502.4B | -166,624.6B | -166,646.1B | -123.16B | -123.16B | -18.16M | -18.59M | -19.4M | -19.82M | -19.5M | -18.2M | -16.96M | -15.26M | -15.56M | -16.16M | -18.83M | -21.62M | -24.78M |
Selling & General & Admin | 12,293.4B | 12,293.7B | 12,291B | 1.99B | 1.99B | 10.34M | 9.09M | 9.03M | 8.45M | 8.37M | 8.45M | 8.5M | 8.68M | 9.39M | 9.43M | 9.13M | 8.99M | 8.74M |
Research & Development | 12,851.8B | 12,853.5B | 12,851B | 3.97B | 3.97B | 9.26M | 11.43M | 12.77M | 13.9M | 13.48M | 11.41M | 9.38M | 7.55M | 7.36M | 7.3M | 10.09M | 12.52M | 15.46M |
Other Expenses | -857K | 117.46B | 117.46B | 117.46B | 117.46B | n/a | n/a | n/a | n/a | n/a | 10K | 9K | 16K | 3K | 12K | -12K | -42K | -29K |
Operating Expenses | 25,145.2B | 25,264.7B | 25,259.4B | 123.42B | 123.42B | 19.6M | 20.52M | 21.8M | 22.35M | 21.86M | 19.85M | 17.88M | 16.23M | 16.76M | 16.72M | 19.21M | 21.51M | 24.2M |
Interest Expense | -362K | -362K | -362K | 362K | 362K | 362K | 362K | 102K | 102K | 102K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 142,600B | 142,600B | 142,600B | 9.79M | 14.93M | 19.6M | 20.52M | 21.8M | 22.35M | 21.86M | 19.85M | 17.88M | 16.23M | 16.76M | 16.72M | 19.21M | 21.51M | 24.2M |
Income Tax Expense | -366K | -366K | -366K | n/a | n/a | -4K | -366K | -786K | -1.03M | -1.12M | -769K | -353K | -110K | -14K | -4K | 4.00 | -60K | -4K |
Shares Outstanding (Basic) | 58.21M | 15.53M | 15.53M | 20.42M | 25.31M | 21.04M | 20.99M | 21M | 20.98M | 20.96M | 20.93M | 20.92M | 20.9M | 20.61M | 15.98M | 15.98M | 15.67M | 14.62M |
Shares Outstanding (Diluted) | 58.21M | 15.53M | 15.53M | 20.42M | 25.31M | 21.04M | 20.99M | 21M | 20.98M | 20.96M | 20.93M | 20.92M | 20.9M | 20.9M | 15.98M | 15.98M | 15.78M | 14.62M |
EPS (Basic) | -10.72M | -10.73M | -10.73M | -4.87K | -4.87K | -0.87 | -0.89 | -0.93 | -0.95 | -0.94 | -0.88 | -0.88 | -0.85 | -0.93 | -1.05 | -1.34 | -1.64 | -2.02 |
EPS (Diluted) | -10.72M | -10.73M | -10.73M | -4.87K | -4.87K | -0.87 | -0.89 | -0.93 | -0.95 | -0.94 | -0.88 | -0.88 | -0.85 | -0.93 | -1.05 | -1.34 | -1.64 | -2.02 |
EBITDA | -166,529.4B | -166,651.5B | -166,646.3B | -123.37B | -123.36B | -19.36M | -20.29M | -21.56M | -22.12M | -21.63M | -19.62M | -17.65M | -16.53M | -17.48M | -16.81M | -19.16M | -20.97M | -23.18M |
EBIT | 3.82M | 3.82M | -1.39M | -9.03M | -14.12M | -18.73M | -19.66M | -21.15M | -21.71M | -21.12M | -19.12M | -17.56M | -11.92M | -7.89M | -3.76M | n/a | -6.27M | -13.61M |
Depreciation & Amortization | -13K | -13K | -9K | 8K | 13K | 17K | 16K | 16K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 15K | 13K |